Artificial chemical entity comprising a DNA oligonucleotide aptamer that selectively… Grant US-11299740-B2 United States of America 12 Apr 2022
USE OF E. COLI STRAINS EXPRESSING HIGH LEVEL OF ALPHA-GAL TO MODULATE IMMUNITY AND… Application WO-2021245207-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and… Grant US-11147868-B2 United States of America 19 Oct 2021
NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF Application EA-038112-B1 Eurasian Patent Organisation 07 Jul 2021
NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF Application WO-2018185494-A1 World Intellectual Property Organisation (WIPO) 11 Oct 2018
NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF Application WO-2018051085-A1 World Intellectual Property Organisation (WIPO) 22 Mar 2018
COMPOUNDS AND THERAPEUTIC USES THEREOF Application WO-2017060729-A1 World Intellectual Property Organisation (WIPO) 13 Apr 2017
COMPOUNDS AND THERAPEUTIC USES THEREOF Application WO-2017060728-A1 World Intellectual Property Organisation (WIPO) 13 Apr 2017